logo

KA(Delisted)

KinetaยทNASDAQ
--
--(--)

KA Profile

Kineta Inc

A company that develops therapies for alzheimer disease, parkinson disease and amyotrophic lateral sclerosis

--
12/13/2006
02/11/2016
NASDAQ Stock Exchange
11
12-31
Common stock
7683 SE 27th Street, Suite 481, Mercer Island, WA 98040
--
Kineta Inc was incorporated in Delaware on December 13, 2006. The company is a clinical-stage biotechnology company with a mission to develop next-generation immunotherapies that can transform patients' lives. Using its expertise in innate immunity, Kineta focuses on discovering and developing potentially differentiated immunotherapies to address the major challenges of current cancer therapies.